Sunday November 22 2009 | Biotechnology feed | All feeds
|
|
FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar ManiaFriday 10th of October 2008 8:00BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:
![]() Browse other news from this organisation: AstraZeneca Related Web-Links(If any, Generated Automatically)![]()
Source PR Newswire |
|